Cognitive Function Analysis and qEEG Study in Long COVID-19 Syndrome Patients
NCT ID: NCT05670418
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
45 participants
OBSERVATIONAL
2022-10-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators conducted assessments utilizing the quantitative electroencephalogram (qEEG) measurement method and interviews using instruments such as the MOCA questionnaire and Self Rating Questionnaire (SRQ). With this qEEG examination, the investigators hoped that there will be an imbalance/abnormality of brain wave activity that arises related to impaired cognitive function.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Executive Functioning and Sleep Fragmentation in COVID-19 Patients
NCT05764096
Personalized Computerized Training Program for Cognitive Dysfunction After COVID-19
NCT05571852
Long-Covid: Treatment of Cognitive Difficulties
NCT05167266
Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19
NCT05582603
Digital Cognition Study During Long-COVID
NCT06391970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The whole procedure will run for approximately 12 weeks based on the long COVID range.
The determinants of long COVID patients include: never been vaccinated, old age, comorbid, female population, and hospitalized patients.
The total number of subjects with the post-COVID syndrome in the proportion test is 30 subjects.
The measuring instruments used to measure the decline in cognitive function are the MOCA questionnaire and Self Rating Questionnaire (SRQ).
The target population is post-COVID-19 patients with Long COVID Syndrome.
The accessible population is post-COVID-19 patients who have been treated at RSCM Kiara and have regular checkups at the RSCM polyclinic with Long COVID Syndrome for 12 weeks or more.
The control population is post-COVID-19 patients who managed to recover without symptoms.
The Long COVID Syndrome patients who meet the inclusion criteria and have signed the consent.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Long COVID-19
Patients post-COVID-19 with Long COVID-19 Syndrome
Quantitative Electroencephalography
Each qEEG examination of one person lasted about 20 minutes and included two stages: the first-recording of brain waves with eyes closed (5 min), the other with eyes open (5 min)
COVID-19
Patients post-COVID-19 without Long COVID-19 Syndrome
Quantitative Electroencephalography
Each qEEG examination of one person lasted about 20 minutes and included two stages: the first-recording of brain waves with eyes closed (5 min), the other with eyes open (5 min)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quantitative Electroencephalography
Each qEEG examination of one person lasted about 20 minutes and included two stages: the first-recording of brain waves with eyes closed (5 min), the other with eyes open (5 min)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Over 18 years old
3. Willing to participate in the research
4. Completed the Montreal Cognitive Assessment (MoCA) and Self Rating Questionnaire (SRQ)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. dr Yetty Ramli SpS
Medical Staff & Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rumah Sakit Cipto Manunkusumo
Jakarta Pusat, DKI Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-05-0578
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.